scispace - formally typeset
G

Georges Kaltenbach

Researcher at University of Strasbourg

Publications -  127
Citations -  3182

Georges Kaltenbach is an academic researcher from University of Strasbourg. The author has contributed to research in topics: Cobalamin & Vitamin B12. The author has an hindex of 25, co-authored 122 publications receiving 2831 citations.

Papers
More filters
Journal ArticleDOI

Prognostic factors of hematologic recovery in nonchemotherapy drug-induced agranulocytosis.

TL;DR: Multivariable analysis showed that neutrophil count 1.5x10 9 /L represents a new low and thus, indirectly, the prognosis in 91 patients with well-established drug-induced agranulocytosis is poor.
Journal ArticleDOI

TDP43-Positive Intraneuronal Inclusions in a Patient with Motor Neuron Disease and Parkinson’s Disease

TL;DR: The assessment of an abnormal reactivity for TDP43 in a patient with motor neuron disease (MND) and Parkinson’s disease (PD) might gain more insight into the pathophysiology of this association of two diseases.
Journal ArticleDOI

Effects of a short-term personalized intermittent work exercise program (IWEP) on maximal cardio-respiratory function and endurance parameters among healthy young and older seniors

TL;DR: The most striking finding in this study is that after only 9 weeks, the short-term “individually-tailored” IWEP significantly improved both maximal cardio-respiratory function and endurance parameters in healthy, previously untrained seniors.
Journal ArticleDOI

Determination of Free Triiodothyronine by Six Different Methods in Patients with Non-Thyroidal Illness and in Patients Treated with Amiodarone

TL;DR: The findings suggest that users of FT3 assays should exercise caution in interpreting results in non-thyroidal illness and amiodarone treated patients, as there are method-related differences in the profiles obtained.
Journal ArticleDOI

Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.

TL;DR: Age may have significant effects on the response to and adverse effects of therapy in ITP, and this should be considered when choosing the treatment modality for the elderly.